Publication | Open Access
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis
10
Citations
17
References
2022
Year
Our results show an increment of CH50 and serum C2 levels in SSc patients in comparison to HC; we retain that CH50 may represent a biomarker of disease severity and of skin and lung fibrosis in these patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1